The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
We will estimate the responses of lansoprazole and ecabet sodium combination therapy and
compare with lansoprazole and placebo therapy in patients who need additional therapy after
standard proton pump inhibitor treatment for 4week or more in recurrent gastroesophageal
reflux disease.